110 related articles for article (PubMed ID: 27017064)
1. [The Glasgow inflammatory score and lung cancer: A predictor of admissions to emergency units].
Gorham J; Ameye L; Paesmans M; Berghmans T; Sculier JP; Meert AP
Rev Mal Respir; 2016 Nov; 33(9):759-765. PubMed ID: 27017064
[TBL] [Abstract][Full Text] [Related]
2. The lung cancer patient at the emergency department: a three-year retrospective study.
Gorham J; Ameye L; Berghmans T; Sculier JP; Meert AP
Lung Cancer; 2013 May; 80(2):203-8. PubMed ID: 23433593
[TBL] [Abstract][Full Text] [Related]
3. The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor in patients with resectable gastric cancer.
Takeno S; Hashimoto T; Shibata R; Maki K; Shiwaku H; Yamana I; Yamashita R; Yamashita Y
Oncology; 2014; 87(4):205-14. PubMed ID: 25034097
[TBL] [Abstract][Full Text] [Related]
4. Clinical utility of the pretreatment glasgow prognostic score in patients with advanced inoperable non-small cell lung cancer.
Leung EY; Scott HR; McMillan DC
J Thorac Oncol; 2012 Apr; 7(4):655-62. PubMed ID: 22425914
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer.
Martin HL; Ohara K; Kiberu A; Van Hagen T; Davidson A; Khattak MA
Intern Med J; 2014 Jul; 44(7):676-82. PubMed ID: 24750233
[TBL] [Abstract][Full Text] [Related]
6. Optimization of the systemic inflammation-based Glasgow prognostic score: a Glasgow Inflammation Outcome Study.
Proctor MJ; Horgan PG; Talwar D; Fletcher CD; Morrison DS; McMillan DC
Cancer; 2013 Jun; 119(12):2325-32. PubMed ID: 23575969
[TBL] [Abstract][Full Text] [Related]
7. Prognostication in advanced cancer: a study examining an inflammation-based score.
Partridge M; Fallon M; Bray C; McMillan D; Brown D; Laird B
J Pain Symptom Manage; 2012 Aug; 44(2):161-7. PubMed ID: 22732417
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment Modified Glasgow Prognostic Score Predicts Clinical Outcomes After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.
Kishi T; Matsuo Y; Ueki N; Iizuka Y; Nakamura A; Sakanaka K; Mizowaki T; Hiraoka M
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):619-26. PubMed ID: 26068494
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of the modified Glasgow prognostic score in patients with advanced head and neck cancer.
Nakayama M; Tabuchi K; Hara A
Head Neck; 2015 Dec; 37(12):1745-9. PubMed ID: 24989115
[TBL] [Abstract][Full Text] [Related]
10. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study.
Proctor MJ; Morrison DS; Talwar D; Balmer SM; Fletcher CD; O'Reilly DS; Foulis AK; Horgan PG; McMillan DC
Eur J Cancer; 2011 Nov; 47(17):2633-41. PubMed ID: 21724383
[TBL] [Abstract][Full Text] [Related]
11. Systemic inflammation and survival of patients with prostate cancer: evidence from the Glasgow Inflammation Outcome Study.
Shafique K; Proctor MJ; McMillan DC; Qureshi K; Leung H; Morrison DS
Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):195-201. PubMed ID: 22343838
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of the high-sensitivity modified Glasgow prognostic score in patients with resectable non-small cell lung cancer.
Osugi J; Muto S; Matsumura Y; Higuchi M; Suzuki H; Gotoh M
J Cancer Res Ther; 2016; 12(2):945-51. PubMed ID: 27461679
[TBL] [Abstract][Full Text] [Related]
13. Modified Glasgow prognostic score is an independent prognostic factor in patients with cervical cancer undergoing chemoradiotherapy.
Xiao Y; Ren YK; Cheng HJ; Wang L; Luo SX
Int J Clin Exp Pathol; 2015; 8(5):5273-81. PubMed ID: 26191228
[TBL] [Abstract][Full Text] [Related]
14. Validation of the Modified Glasgow Prognostic Score in Advanced Cancer Patients Receiving Palliative Care.
Pantano Nde P; Paiva BS; Hui D; Paiva CE
J Pain Symptom Manage; 2016 Feb; 51(2):270-7. PubMed ID: 26598040
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of the role of inflammation in renal cancer.
Qayyum T; McArdle PA; Lamb GW; Going JJ; Orange C; Seywright M; Horgan PG; Oades G; Aitchison MA; Edwards J
Urol Int; 2012; 88(3):277-81. PubMed ID: 22377628
[TBL] [Abstract][Full Text] [Related]
16. Does the modified Glasgow Prognostic Score (mGPS) have a prognostic role in esophageal cancer?
Walsh SM; Casey S; Kennedy R; Ravi N; Reynolds JV
J Surg Oncol; 2016 Jun; 113(7):732-7. PubMed ID: 27004839
[TBL] [Abstract][Full Text] [Related]
17. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio.
Wei XL; Wang FH; Zhang DS; Qiu MZ; Ren C; Jin Y; Zhou YX; Wang DS; He MM; Bai L; Wang F; Luo HY; Li YH; Xu RH
BMC Cancer; 2015 May; 15():350. PubMed ID: 25934640
[TBL] [Abstract][Full Text] [Related]
18. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
19. The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer.
Hefler-Frischmuth K; Seebacher V; Polterauer S; Tempfer C; Reinthaller A; Hefler L
Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):102-5. PubMed ID: 20080329
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of a systemic inflammatory response in patients undergoing multimodality therapy for advanced colorectal cancer.
Inoue Y; Iwata T; Okugawa Y; Kawamoto A; Hiro J; Toiyama Y; Tanaka K; Uchida K; Mohri Y; Miki C; Kusunoki M
Oncology; 2013; 84(2):100-7. PubMed ID: 23147449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]